Cannabis

Among young adults aged 19 to 30 years and early midlife adults aged 35 to 50 years, past-year use of cannabis and hallucinogens remained at “historically high” levels in 2023, according to the Monitoring the Future Panel Study Annual Report.

New laws affecting the recreational or medicinal use of cannabis may be associated with changes in the use of prescription drugs to treat mental health disorders, but these links varied by drug class and state, according to a recent study.

A population-based, retrospective cohort study revealed that postmenopausal women with a history of hormone therapy use were biologically younger than those with no history of hormone therapy.

NEW YORK — In this Healio Video Perspective, Hyun Jung Kim, MD, discusses the format of her presentation on the relationship between cannabis use and risk for psychosis at the American Psychiatric Association Annual Meeting.

Despite lack of evidence, midlife women report using cannabis to manage symptoms overlapping with menopause including insomnia, anxiety, mood and musculoskeletal pain, according to results of two studies.

Among patients admitted to the cardiac ICU, those engaging in recreational drug use were almost three times as likely to experience a repeat serious CV event within 1 year compared with nonusers, researchers reported.

A topical cream containing cannabis “significantly reduced the severity of itching” symptoms in patients with chronic kidney disease-related pruritus, according to published data.

The ACP recently recommended an evidence-based, public health-focused approach to addressing cannabis use.

Individuals with cannabis-related disorder exhibited increased risk for head and neck cancer, results of a retrospective cohort study showed.

Prenatal cannabis may be linked to multiple adverse maternal health outcomes, study results published in JAMA Internal Medicine suggest.